VKH
OSIR

Virtu KCG Holdings’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Virtu KCG Holdings’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-18,455
Closed -$91K – 4208
2016
Q4 		$91K Buy
18,455
+8,107
+78% +$41.5K ﹤0.01% 2950
2016
Q3 		$51K Buy
+10,348
New +$53K ﹤0.01% 2779
2016
Q2 		– Sell
-14,044
Closed -$80K – 3697
2016
Q1 		$80K Buy
+14,044
New +$98.1K ﹤0.01% 2373

Other funds holding OSIR

HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Virtu KCG Holdings's OSIR Position: Q1 2017 in Review

Virtu KCG Holdings sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2017, closing a stake of 18,455 shares — an estimated $91K sold.

Virtu KCG Holdings first reported a position in OSIR in Q1 2016 and held it in 3 quarters. The position peaked at $91K in Q4 2016. 11 funds tracked by Wall St. Rank hold OSIR as of Q1 2017.

  • Virtu KCG Holdings reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 18,455 Osiris Therapeutics, Inc. Common Stock shares in Q1 2017, an estimated $91K.
  • Virtu KCG Holdings first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2016 and held it in 3 quarters.
  • Virtu KCG Holdings's Osiris Therapeutics, Inc. Common Stock position peaked at $91K in Q4 2016.
  • 11 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.